Alto Neuroscience, Inc. (ANRO) Misses Q3 EPS by 6c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
• Guggenheim Reiterates Buy Rating on Rubrik Inc (RBRK)
• H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)